These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7587043)
41. [The use of stepwise antibacterial therapy of community-acquired pneumonia]. Iashchenko AV; Sinopal'nikov AI Klin Med (Mosk); 2014; 92(6):53-6. PubMed ID: 25799831 [TBL] [Abstract][Full Text] [Related]
42. [Clinical efficacy of probiotics in complex treatment of called-up servicemen with community-acquired pneumonia]. Rakov AL; Grinevich VB; Kriukov AE; Bogdanov IV; Rysev AV; Zakharchenko MM; Dobrenko VA; Gubonina IV Voen Med Zh; 2006 Apr; 327(4):15-22. PubMed ID: 16784101 [No Abstract] [Full Text] [Related]
43. Role of gemifloxacin in community-acquired pneumonia. Tillotson GS Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107 [TBL] [Abstract][Full Text] [Related]
44. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study. DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L Trials; 2015 Aug; 16():355. PubMed ID: 26272324 [TBL] [Abstract][Full Text] [Related]
45. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? Halm EA; Switzer GE; Mittman BS; Walsh MB; Chang CC; Fine MJ J Gen Intern Med; 2001 Sep; 16(9):599-605. PubMed ID: 11556940 [TBL] [Abstract][Full Text] [Related]
46. Community-acquired pneumonia: treatment at home or in the hospital? Aujesky D; Fine MJ Am J Med; 2008 Dec; 121(12):1038-40. PubMed ID: 19028194 [No Abstract] [Full Text] [Related]
47. Approaches to drug therapy, formulary, and pathway management in a large community hospital. Halley HJ Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S17-21. PubMed ID: 11098316 [TBL] [Abstract][Full Text] [Related]
51. [Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins]. Starodubtseva OI; Vakhrushev IaM Probl Tuberk Bolezn Legk; 2009; (6):28-9. PubMed ID: 19642570 [TBL] [Abstract][Full Text] [Related]
52. Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil. Hendrickson JR; North DS Ann Pharmacother; 1995 Jun; 29(6):561-5. PubMed ID: 7663025 [TBL] [Abstract][Full Text] [Related]
53. Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study. Siegel RE; Alicea M; Lee A; Blaiklock R Am J Ther; 1999 Jul; 6(4):217-22. PubMed ID: 11329100 [TBL] [Abstract][Full Text] [Related]
54. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis. Marras TK; Nopmaneejumruslers C; Chan CK Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587 [TBL] [Abstract][Full Text] [Related]
56. It's time to step up the management of community-acquired pneumonia. Idemyor V J Natl Med Assoc; 2002 Mar; 94(3):178-81. PubMed ID: 11918388 [TBL] [Abstract][Full Text] [Related]
57. A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study. Engel MF; Bruns AH; Hulscher ME; Gaillard CA; Sankatsing SU; Teding van Berkhout F; Emmelot-Vonk MH; Kuck EM; Steeghs MH; den Breeijen JH; Stellato RK; Hoepelman AI; Oosterheert JJ Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1897-908. PubMed ID: 24859925 [TBL] [Abstract][Full Text] [Related]
58. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection. Quenzer RW; Pettit KG; Arnold RJ; Kaniecki DJ Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367 [TBL] [Abstract][Full Text] [Related]
59. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home. Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506 [TBL] [Abstract][Full Text] [Related]
60. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]